CCG-1423 is an inhibitor of Rho/MRTF/SRF pathway. CCG-1423 shows activities in several cancer cells. CCG-1423 is a promising lead compound for the development of novel pharmacologic tools, and it can be used for the research of cancer and diabetes[1][2][3].
1023.05RON
În stoc
Număr Catalog 804-HY-13991CategorieAfaceri și industrie > Știință și laboratorFurnizorMedChemExpressGentaurDimensiune200mgTipsingle